These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 7391837

  • 1. Studies of skeletal tracer kinetics. IV. Optimum time delay for Tc-99m(Sn) methylene disphosphonate bone imaging.
    Makler PT, Charkes ND.
    J Nucl Med; 1980 Jul; 21(7):641-5. PubMed ID: 7391837
    [Abstract] [Full Text] [Related]

  • 2. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
    Mele M, Conte E, Fratello A, Pasculli D, Pieralice M, D'Addabbo A.
    J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
    [Abstract] [Full Text] [Related]

  • 3. Studies in skeletal tracer kinetics. V: Computer-simulated Tc-99m (Sn)MDP bone-scan changes in some systemic disorders: concise communication.
    Charkes ND, Makler PT.
    J Nucl Med; 1981 Jul; 22(7):601-5. PubMed ID: 6454764
    [Abstract] [Full Text] [Related]

  • 4. Tc-99m methylene diphosphonate (MDP) bone imaging: optimum normal bone scan by optimum time delay?
    Buell U.
    J Nucl Med; 1981 Jan; 22(1):95-6. PubMed ID: 7452362
    [No Abstract] [Full Text] [Related]

  • 5. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
    Blake GM, Moore AE, Fogelman I.
    Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
    [Abstract] [Full Text] [Related]

  • 6. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U, Kleinhans E, Zorn-Bopp E, Reuschel W, Muenzing W, Moser EA, Seiderer M.
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [Abstract] [Full Text] [Related]

  • 7. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
    Littlefield JL, Rudd TG.
    J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
    [Abstract] [Full Text] [Related]

  • 8. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA, Tofe AJ, Benedict JJ, Francis MD, Barnett BL.
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [Abstract] [Full Text] [Related]

  • 9. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA, Tofe AJ, Benedict JJ, Francis MD, Barnett BL.
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [Abstract] [Full Text] [Related]

  • 10. [Bone metabolism in thalassemic children with multiple transfusions. Compartmental analysis of 99mTc-Sn-MDP kinetics].
    Mele M, De Mattia D, D'Addabbo A, Schettini F, Lauriero F, Rubini G.
    Radiol Med; 1989 Nov; 78(5):455-60. PubMed ID: 2608933
    [Abstract] [Full Text] [Related]

  • 11. Labeling efficiency and stomach concentration in methylene diphosphonate bone imaging.
    Dhawan V, Yeh SD.
    J Nucl Med; 1979 Jul; 20(7):791-3. PubMed ID: 541718
    [Abstract] [Full Text] [Related]

  • 12. [Quantitative whole-body bone scintigraphy. II. Pharmacokinetics of osteotropic radiopharmaceuticals (author's transl)].
    Anger K, Aigner S, Bühler M, Umbach I.
    Nuklearmedizin; 1980 Jul; 19(3):97-107. PubMed ID: 7465432
    [Abstract] [Full Text] [Related]

  • 13. A computer assisted comparison of 99Tcm-methylene-diphosphonate and 99Tcm-pyrophosphate bone imaging.
    Büll U, Pfeifer JP, Niendorf HP, Tongendorff J.
    Br J Radiol; 1977 Sep; 50(597):629-36. PubMed ID: 198055
    [Abstract] [Full Text] [Related]

  • 14. Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.
    Rudd TG, Allen DR, Hartnett DE.
    J Nucl Med; 1977 Sep; 18(9):872-6. PubMed ID: 197133
    [Abstract] [Full Text] [Related]

  • 15. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
    Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD.
    J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
    [Abstract] [Full Text] [Related]

  • 16. A clinical comparison of Tc-99m HEDP and Tc-99m MDP in the detection of bone metastases: concise communication.
    Fogelman I, Citrin DL, McKillop JH, Turner JG, Bessent RG, Greig WR.
    J Nucl Med; 1979 Feb; 20(2):98-101. PubMed ID: 430202
    [Abstract] [Full Text] [Related]

  • 17. The effect of radiopharmaceutical incubation time on bone scan quality.
    Henkin RE, Woodruff A, Chang W, Green AM.
    Radiology; 1980 May; 135(2):463-6. PubMed ID: 6445072
    [Abstract] [Full Text] [Related]

  • 18. Factors influencing the distribution of 99m-technetium methylene diphosphonate in bone and soft tissues.
    Khan RA.
    Experientia; 1978 Dec 15; 34(12):1598-600. PubMed ID: 32068
    [Abstract] [Full Text] [Related]

  • 19. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content.
    Domstad PA, Coupal JJ, Kim EE, Blake JS, DeLand FH.
    Radiology; 1980 Jul 15; 136(1):209-11. PubMed ID: 6446106
    [Abstract] [Full Text] [Related]

  • 20. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
    Wang TS, Fawwaz RA, Johnson LJ, Mojdehi GE, Johnson PM.
    J Nucl Med; 1980 Aug 15; 21(8):767-70. PubMed ID: 7400832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.